Viridian Therapeutics’ $258.8 Million Follow-on Public Offering

Leila Ahmed
Tagged:

Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters.Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here